STOCK REPORT · MDLN · NASDAQ
Medline
Star it to add it to your market report.
Overall grade
44 pointsLower-middle bandOverall 44 points · Grade C, 6 points to Grade B
Financial summary
Medline (MDLN) has an overall grade of C from financial statements, with a score of 44 out of 100. Category scores are Earnings 43 (Grade C), Financial health 70 (Grade A) and Dividends 10 (Grade D). Data as of Oct 23, 2026.
Reported figures: ROE 4.93%, Operating margin 0.82%, Revenue growth +11.6%, Debt-to-equity ratio 66.26%, Current ratio 433.3%, Interest coverage 2.72x, Dividend yield 0%, Payout ratio 0%, Dividend streak 0 yrs. Valuation: PER 87.2x, PBR 2.64x, Market cap $46.9B.
The earnings metrics are trailing twelve month values from Yahoo Finance, and the period ends in Jun 2026. The share price was collected from Yahoo Finance on Oct 23, 2026. PER and PBR are the values Yahoo Finance supplied, used as they came. How the grades are calculated is set out in the grading methodology.
This summary restates reported financial figures. It does not forecast share prices or returns.
Valuation
52-week range
Now at 17% of rangeWithin their own 52-week ranges, 7.3% of major US stocks sit lower than this one.
About these metrics
- PER
- Price to earnings ratio (market cap ÷ annual net profit). A lower value means a lower price relative to profit.
- PBR
- Price to book ratio (market cap ÷ net assets). Below 1x, the market value is below book value.
- Market cap
- Share price × shares outstanding. The value the market puts on the whole company.
- 52-week high
- The highest share price over the past year.
- 52-week low
- The lowest share price over the past year.
Scores by category
Each metric out of 100 · category score is the average of threeEarnings
40% of overall · Lower-middle bandEach metric is scored out of 100, and the 43 above is the average of the three scores.
Metrics with values3 of 3
As of Jun 2026
About these metrics
- ROE
- Return on equity. How much profit the company made on its own capital (equity).
- Operating margin
- Operating profit as a share of revenue: what the core business keeps.
- Revenue growth
- How much revenue changed compared with a year earlier.
Financial health
35% of overall · Upper bandEach metric is scored out of 100, and the 70 above is the average of the three scores.
Metrics with values3 of 3
Interest coverage is divided by interest expense from the income statement.
About these metrics
- Debt-to-equity ratio
- Borrowings as a share of equity. Trade payables and advances are left out, so it reads lower than the Korean basis.
- Current ratio
- Assets that can turn into cash within a year, as a share of debts due within a year. At 100% or more they cover those debts.
- Interest coverage
- How many times operating profit covers interest expense. Below 1x, operating profit does not cover interest.
Dividends
25% of overall · Bottom bandEach metric is scored out of 100, and the 10 above is the average of the three scores.
Metrics with values3 of 3
About these metrics
- Dividend yield
- Dividends paid over a year as a share of the current share price.
- Payout ratio
- The share of profit paid out as dividends. A very high ratio can be hard to keep up.
- Dividend streak
- How many years in a row the company has paid a dividend.
Metric scores are shown rounded to one decimal place, so a category score can differ by up to 1 point from a plain average of the three shown.
Strengths · Weaknesses
Strengths
- Ample short-term liquidity (current ratio 433.3%)
Weaknesses
- Low profit relative to equity (ROE 4.93%)Below the median 9.2% of 63 Healthcare stocks
- Low profitability in the core business (operating margin 0.82%)Below the median 13.0% of 67 Healthcare stocks
- Share price is high relative to earnings (PER 87.2x)Above the median 34.3x of 52 Healthcare stocks
Only metrics that stand out as clearly good or weak against general benchmarks are listed. Where a comparison is possible, the position against the median of stocks in the same sector is shown too. The stock count on each sector line covers only stocks with that metric, so it differs by metric.
Metrics that moved the overall score
- Current ratio+5.8 pts
- Revenue growth+3.5 pts
- Debt-to-equity ratio+3.0 pts
- ROE-1.4 pts
- Interest coverage-1.7 pts
- Payout ratio-3.1 pts
- Dividend yield-3.3 pts
- Dividend streak-3.3 pts
- Operating margin-4.7 pts
Metric scores run up to 100, and the middle score is 50. If all nine metrics scored 50, the overall score would also be 50. Each bar is the contribution of one metric: how far its score sits from the 50 baseline, converted by that metric weight. Right means it raised the overall score, left means it lowered it.
Adding the nine contributions above to the baseline gives 44.8 points, and this stock's overall score is 44. The overall score is calculated from unrounded metric scores and then truncated, while the contributions here are rounded to one decimal place, so the two can differ by up to 1 point. Metrics that are not measured values still carry a contribution, because their scores did go into the overall score and hiding them would hide part of the basis of the grade.
| Metric | Medline | Sector median | Rank in sector |
|---|---|---|---|
| PER | 87.2x | 34.3x | |
| PBR | 2.6x | 6.7x | |
| ROE | 4.9% | 9.2% | |
| Operating margin | 0.8% | 13.0% | |
| Debt-to-equity ratio | 66.3% | 54.9% | |
| Dividend yield | 0.0% | 0.7% |
Grey values on the right are sector medians
Metric ranks in sector
Closer to 1st sits further left- PERRank 47 of 52, top 90%
- PBRRank 17 of 65, top 26%
- ROERank 42 of 63, top 67%
- Operating marginRank 53 of 67, top 79%
- Debt-to-equity ratioRank 39 of 64, top 61%
- Dividend yieldRank 41 of 52, top 79%
On the rank strip, the left end is 1st. PER, PBR and debt-to-equity ratio are ranked from the lowest value, and ROE, operating margin and dividend yield from the highest.
Healthcare stocks close in market cap rank
Sector medians cover the 71 Healthcare stocks listed on Jupick. Typical levels differ by sector, so this is reference information for a simple comparison and not a basis for investment decisions.
About these metrics
- PER
- Price to earnings ratio (market cap ÷ annual net profit). A lower value means a lower price relative to profit.
- PBR
- Price to book ratio (market cap ÷ net assets). Below 1x, the market value is below book value.
- ROE
- Return on equity. How much profit the company made on its own capital (equity).
- Operating margin
- Operating profit as a share of revenue: what the core business keeps.
- Debt-to-equity ratio
- Borrowings as a share of equity. Trade payables and advances are left out, so it reads lower than the Korean basis.
- Dividend yield
- Dividends paid over a year as a share of the current share price.
Where this score sits
16% of the major stocks graded by Jupick score lower than this. Stocks in the same Grade C: 126.
- S172.8%
- A14524.2%
- B28948.2%
- CThis stock12621%
- D233.8%
The Grade C band runs from 30 to 49 points, 20 points wide. This stock's 44 points sit 14 points above the lower boundary, and 6 points remain to 50, where Grade B starts.
Within the Healthcare sector alone, it ranks No. 58 of 71 stocks with an overall score, and the median overall score of the sector is 60.
Unlike metric values, the overall score uses the same baseline for every market and currency, so Korean and US stocks share one sample. The grade boundaries of 85, 70, 50 and 30 points apply equally to every stock, so the counts above are how the sample actually splits at those boundaries. Because one point can decide a grade, two stocks with different grades can be closer in score than two stocks with the same grade. The shares and ranks here describe only the major stocks Jupick covers, not every listed stock.
Schedule
Earnings release
A date announced by the company.
The day the company publishes quarterly or annual results. Only the release date is covered, not the results. Release times are not covered, so only the date (Korea time) is shown. After the release, metrics such as revenue growth are updated at the next data refresh. For information only. Not investment advice.
Stocks with similar score profiles
| Stock | Earnings | Financial health | Dividends |
|---|---|---|---|
| Medline (MDLN, this stock) | 43 | 70 | 10 |
| CNatera | 40 | 69 | 10 |
| CDatadog | 50 | 70 | 10 |
| CSK Bioscience | 40 | 79 | 10 |
| CBlock | 46 | 80 | 10 |
Medline (MDLN) has category scores of Earnings 43 · Financial health 70 · Dividends 10. These are the four major stocks graded in all three categories whose profiles come closest, and no category differs by more than 10 points.
The three scores are given by Jupick from public financial metrics, each out of 100. A similar profile means similar grading results only. It does not mean the share prices move alike.
Ratios as amounts
Base ₩10,000Every ratio metric of this stock, restated on the same amount. If each line used a different base, the amounts could not be compared, so every line starts from ₩10,000.
For every ₩10,000 of revenue: operating profit ₩80.Operating margin 0.8%
- For every ₩10,000 of equityyearly net profit ₩490
- If last year's revenue was ₩10,000this year's revenue ₩11,160
- For every ₩10,000 of equitydebt owed ₩6,630
- For every ₩10,000 of debt due within a yearassets turning into cash within a year ₩43,330
- For every ₩10,000 of interestoperating profit ₩27,000
- For ₩10,000 of net profitmarket value ₩872,000
- For ₩10,000 of book equitymarket value ₩26,000
The ₩10,000 base is an assumption chosen for easy reading, not this company's actual revenue or equity. The values multiply the ratios shown as they are and round to the nearest won, so they can differ from the source by a few won. Metrics that make no sense as amounts are left out: values that are not measured, values that cannot be confirmed as measured, and loss-making cases where the base amount does not hold. This stock does not report in won, but ratios do not depend on currency, so the amounts are shown in won.
Metrics that decide the grade
Overall 44 · Grade CThe overall score recalculated with just one of the nine metrics set to the middle score of 50. Only one metric changes at a time, and the other eight stay as they are.
With any single metric at 50, the overall score stays in Grade C.
The metric closest to a boundary is Operating margin. With only this metric at 50, the overall score would be 48.7, 1.3 points from the 50 point boundary. Earnings · metric 14.9 · contribution -4.7
The scores above add up this stock's metric scores again with one of them set to 50. They are not new grades, and this stock's grade stays at C. Metric scores and contributions are rounded to one decimal place, so a change within 1 point of a boundary is not reported as a grade change. Changing two or more metrics at once was not calculated.
Where the share price enters the grade
The grade above turns 9 metrics into scores and combines them. Counting how many of them use the share price shows whether the grade moves when the price moves.
The 9 graded metrics stay the same when the share price moves.
- Earnings grade metrics (3)Does not use the share price0 of 3 metrics use the share price
- Financial health grade metrics (3)Does not use the share price0 of 3 metrics use the share price
- Dividends grade metrics (3)Does not use the share price0 of 3 metrics use the share price
- PER and PBRCome from the share price but are not scoredNot graded
For US stocks, Dividend yield uses dividends and the share price, but for this stock that metric holds no value divided by the price. All 9 graded metrics come from financial statements and dividend history.
Stocks with a value for each metric
The grade above uses 9 metrics. Each line shows how many major stocks have a value for that metric, so you can tell whether a blank is specific to this stock or common to most stocks.
All 9 graded metrics have values.
- ROEHas a value567 of 600 stocks have a value
- Operating marginHas a value562 of 600 stocks have a value
- Revenue growthHas a value570 of 600 stocks have a value
- Debt-to-equity ratioHas a value559 of 600 stocks have a value
- Current ratioHas a value545 of 600 stocks have a value
- Interest coverageHas a value278 of 600 stocks have a value
- Dividend yieldHas a value519 of 600 stocks have a value
- Payout ratioHas a value507 of 600 stocks have a value
- Dividend streakHas a value595 of 600 stocks have a value
All 9 metrics of this stock are measured values.
Position in the market distribution
US stocksWhere the value of Medline sits when the US stocks on Jupick are lined up from the smallest value, ignoring sector. Left is smaller, right is larger, and the shaded part is the middle half.
The thin lower axis counts the position again within the same sector (Healthcare) only. All metrics with a lower axis sit in the same band as the whole market.
- PER87.2x
- PBR2.6x
- ROE4.9%
- Operating margin0.8%
- Debt-to-equity ratio66.3%
- Dividend yield0.0%
Won and dollar stocks have different metric levels, so they are counted in separate samples. This is only where a value sits in a line-up, not a sign of good or bad and not an investment judgement. Stocks without the metric, and loss-making stocks where PER or PBR does not hold, are left out of the sample. The remaining sample size is shown on each line. The sector axis is not drawn when the same-currency, same-sector sample has fewer than 8 stocks.
In Korean won
Dollar amounts converted at the exchange rate below, to compare their size with Korean stocks in the same unit.
Reference values calculated at the rate shown above. Actual trades and currency exchange use the rate and fees of the broker, so amounts differ. The 52-week high and low are not converted, because it is not known when they were set and so no rate can be chosen.
Korean and US yardsticks
Healthcare sectorWhere one value of Medline sits among US stocks in the same sector, and among Korean stocks. Only ratio metrics that compare across currencies are used.
4 of the 6 compared metrics sit in different bands on the two yardsticks.
- ROE 4.9% US 31 stocks · lowest quarter · 12.9% have a smaller value Korean 32 stocks · upper middle · 53.1% have a smaller value Gap between yardsticks 40.2 pp
- Debt-to-equity ratio 66.3% US 32 stocks · lower middle · 43.8% have a smaller value Korean 32 stocks · highest quarter · 75% have a smaller value Gap between yardsticks 31.2 pp
- Operating margin 0.8% US 37 stocks · lowest quarter · 8.1% have a smaller value Korean 30 stocks · lower middle · 36.7% have a smaller value Gap between yardsticks 28.6 pp
- PBR 2.6x US 33 stocks · lowest quarter · 24.2% have a smaller value Korean 32 stocks · lower middle · 25% have a smaller value Gap between yardsticks 0.8 pp
Only metrics with at least 8 stocks on both sides are compared.
Next
Investment notice
For information only. Not investment advice. Grades and figures are reference material calculated from public information. They do not ask anyone to trade a security and make no promise of returns. You are solely responsible for your investment decisions and their results, and Jupick accepts no legal liability for them.